STVN Stevanato Group
- 20.030
- +0.030+0.15%
- 20.030
- 0.0000.00%
Stevanato Group News
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $24
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $24
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $24
UBS Initiates Stevanato Group(STVN.US) With Hold Rating, Announces Target Price $24
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Raises Target Price to $24
Cautious Hold Rating on Stevanato Group Amid Margin Expansion Challenges and Cost Concerns
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
BofA Securities Maintains Stevanato Group(STVN.US) With Buy Rating, Announces Target Price $24
Citi Maintains Stevanato Group(STVN.US) With Buy Rating, Maintains Target Price $28
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Stevanato Group (STVN)
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Jefferies Maintains Stevanato Group(STVN.US) With Hold Rating, Cuts Target Price to $20
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Sticks to Its Hold Rating for Stevanato Group (STVN)
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Pharvaris (PHVS) and Stevanato Group (STVN)
Analysis
Price Target
No Data
No Data